The forming radioligand [99mTc]Tc-Demobesin 1 ([99mTc]Tc-DB1) was the first radiolabeled GRPR antagonist tested in PC-3 tumor-bearing mice showing excellent and specific receptor targeting properties, combining high accumulation in the experimental tumor with a fast background clearance via the kidneys into urine. Here, GRPR is linked to neoplasm.